130 related articles for article (PubMed ID: 36842430)
1. Operando NMR metabolomics of a microfluidic cell culture.
Rogers G; Barker S; Sharma M; Khakoo S; Utz M
J Magn Reson; 2023 Apr; 349():107405. PubMed ID: 36842430
[TBL] [Abstract][Full Text] [Related]
2. Metabolic profiling of normal hepatocyte and hepatocellular carcinoma cells via
Chen Y; Chen Z; Feng JH; Chen YB; Liao NS; Su Y; Zou CY
Cell Biol Int; 2018 Apr; 42(4):425-434. PubMed ID: 29144590
[TBL] [Abstract][Full Text] [Related]
3. The aspartate metabolism pathway is differentiable in human hepatocellular carcinoma: transcriptomics and (13) C-isotope based metabolomics.
Darpolor MM; Basu SS; Worth A; Nelson DS; Clarke-Katzenberg RH; Glickson JD; Kaplan DE; Blair IA
NMR Biomed; 2014 Apr; 27(4):381-9. PubMed ID: 24497316
[TBL] [Abstract][Full Text] [Related]
4.
Gao L; Wang KX; Zhang NN; Li JQ; Qin XM; Wang XL
J Proteome Res; 2018 May; 17(5):1833-1843. PubMed ID: 29589762
[No Abstract] [Full Text] [Related]
5. Microfluidic chip for isolation of viable circulating tumor cells of hepatocellular carcinoma for their culture and drug sensitivity assay.
Zhang Y; Zhang X; Zhang J; Sun B; Zheng L; Li J; Liu S; Sui G; Yin Z
Cancer Biol Ther; 2016 Nov; 17(11):1177-1187. PubMed ID: 27662377
[TBL] [Abstract][Full Text] [Related]
6. 1H-NMR-based metabolomics reveals the biomarker panel and molecular mechanism of hepatocellular carcinoma progression.
Wang KX; Du GH; Qin XM; Gao L
Anal Bioanal Chem; 2022 Feb; 414(4):1525-1537. PubMed ID: 35024914
[TBL] [Abstract][Full Text] [Related]
7. (1)H-NMR-based metabolomics of tumor tissue for the metabolic characterization of rat hepatocellular carcinoma formation and metastasis.
Wang J; Zhang S; Li Z; Yang J; Huang C; Liang R; Liu Z; Zhou R
Tumour Biol; 2011 Feb; 32(1):223-31. PubMed ID: 20890798
[TBL] [Abstract][Full Text] [Related]
8. Radiation-Induced Metabolic Shifts in the Hepatic Parenchyma: Findings from
Chung YH; Tsai CK; Yu CF; Wang WL; Yang CL; Hong JH; Yen TC; Chen FH; Lin G
Molecules; 2021 Apr; 26(9):. PubMed ID: 33925109
[TBL] [Abstract][Full Text] [Related]
9. Time-resolved non-invasive metabolomic monitoring of a single cancer spheroid by microfluidic NMR.
Patra B; Sharma M; Hale W; Utz M
Sci Rep; 2021 Jan; 11(1):53. PubMed ID: 33420162
[TBL] [Abstract][Full Text] [Related]
10. Time-resolved NMR metabolomics of plant cells based on a microfluidic chip.
Maisch J; Kreppenhofer K; Büchler S; Merle C; Sobich S; Görling B; Luy B; Ahrens R; Guber AE; Nick P
J Plant Physiol; 2016 Aug; 200():28-34. PubMed ID: 27318870
[TBL] [Abstract][Full Text] [Related]
11. Hepatocellular carcinoma cells and their fibrotic microenvironment modulate bone marrow-derived mesenchymal stromal cell migration in vitro and in vivo.
Garcia MG; Bayo J; Bolontrade MF; Sganga L; Malvicini M; Alaniz L; Aquino JB; Fiore E; Rizzo MM; Rodriguez A; Lorenti A; Andriani O; Podhajcer O; Mazzolini G
Mol Pharm; 2011 Oct; 8(5):1538-48. PubMed ID: 21770423
[TBL] [Abstract][Full Text] [Related]
12. PIWIL1 governs the crosstalk of cancer cell metabolism and immunosuppressive microenvironment in hepatocellular carcinoma.
Wang N; Tan HY; Lu Y; Chan YT; Wang D; Guo W; Xu Y; Zhang C; Chen F; Tang G; Feng Y
Signal Transduct Target Ther; 2021 Feb; 6(1):86. PubMed ID: 33633112
[TBL] [Abstract][Full Text] [Related]
13. Microbiome and Metabolomics in Liver Cancer: Scientific Technology.
Ganesan R; Yoon SJ; Suk KT
Int J Mol Sci; 2022 Dec; 24(1):. PubMed ID: 36613980
[TBL] [Abstract][Full Text] [Related]
14. Plasma metabolomic analysis of human hepatocellular carcinoma: Diagnostic and therapeutic study.
Chen Y; Zhou J; Li J; Feng J; Chen Z; Wang X
Oncotarget; 2016 Jul; 7(30):47332-47342. PubMed ID: 27322079
[TBL] [Abstract][Full Text] [Related]
15. Global Metabolic Profiling Identifies a Pivotal Role of Proline and Hydroxyproline Metabolism in Supporting Hypoxic Response in Hepatocellular Carcinoma.
Tang L; Zeng J; Geng P; Fang C; Wang Y; Sun M; Wang C; Wang J; Yin P; Hu C; Guo L; Yu J; Gao P; Li E; Zhuang Z; Xu G; Liu Y
Clin Cancer Res; 2018 Jan; 24(2):474-485. PubMed ID: 29084919
[No Abstract] [Full Text] [Related]
16. NMR and LC/MS-based global metabolomics to identify serum biomarkers differentiating hepatocellular carcinoma from liver cirrhosis.
Liu Y; Hong Z; Tan G; Dong X; Yang G; Zhao L; Chen X; Zhu Z; Lou Z; Qian B; Zhang G; Chai Y
Int J Cancer; 2014 Aug; 135(3):658-68. PubMed ID: 24382646
[TBL] [Abstract][Full Text] [Related]
17. Urinary nuclear magnetic resonance spectroscopy of a Bangladeshi cohort with hepatitis-B hepatocellular carcinoma: A biomarker corroboration study.
Cox IJ; Aliev AE; Crossey MM; Dawood M; Al-Mahtab M; Akbar SM; Rahman S; Riva A; Williams R; Taylor-Robinson SD
World J Gastroenterol; 2016 Apr; 22(16):4191-200. PubMed ID: 27122669
[TBL] [Abstract][Full Text] [Related]
18. Zonation related function and ubiquitination regulation in human hepatocellular carcinoma cells in dynamic vs. static culture conditions.
Cheng S; Prot JM; Leclerc E; Bois FY
BMC Genomics; 2012 Feb; 13():54. PubMed ID: 22296956
[TBL] [Abstract][Full Text] [Related]
19. NMR-based metabolic profiling of human hepatoma cells in relation to cell growth by culture media analysis.
Miccheli AT; Miccheli A; Di Clemente R; Valerio M; Coluccia P; Bizzarri M; Conti F
Biochim Biophys Acta; 2006 Nov; 1760(11):1723-31. PubMed ID: 17052856
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
